PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Pathology and Translational Medicine10.4132/jptm.2017.10.17201852114-20The Significance of TROP2 Expression in Predicting BRAF Mutations in Papillary Thyroid CarcinomaJoon Seog Kong, Hyeon Jin Kim, Min-Jung Kim, Areumnuri Kim, Dalnim Lee, Kanghee Han, Sunhoo Park, Jae Soo Koh, Jae Kyung Myunghttp://www.jpatholtm.org/upload/pdf/jptm-2017-10-17.pdf, http://www.jpatholtm.org/journal/view.php?doi=10.4132/jptm.2017.10.17, http://www.jpatholtm.org/upload/pdf/jptm-2017-10-17.pdf
Nature Clinical Practice Endocrinology & Metabolism10.1038/ncpendmet0161200624180-181Significance of BRAF mutations in papillary thyroid carcinoma: prognostic and therapeutic implicationsLionel Groussin, James A Faginhttp://www.nature.com/articles/ncpendmet0161.pdf, http://www.nature.com/articles/ncpendmet0161, http://www.nature.com/articles/ncpendmet0161.pdf
Yearbook of Endocrinology10.1016/s0084-3741(09)79273-x20092009143-144High Rate of BRAF and RET/PTC Dual Mutations Associated with Recurrent Papillary Thyroid CarcinomaM. Schotthttp://api.elsevier.com/content/article/PII:S008437410979273X?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S008437410979273X?httpAccept=text/plain
Yearbook of Surgery10.1016/s0090-3671(08)70420-820062006157Type and Prevalence of BRAF Mutations Are Closely Associated With Papillary Thyroid Carcinoma Histotype and Patients' Age But Not With Tumour AggressivenessT.J. Faheyhttp://api.elsevier.com/content/article/PII:S0090367108704208?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S0090367108704208?httpAccept=text/plain
Scientific Reports10.1038/s41598-017-04948-3201771 BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node MetastasesNajla Fakhruddin, Mark Jabbour, Michael Novy, Hani Tamim, Hisham Bahmad, Fadi Farhat, Ghazi Zaatari, Tarek Aridi, Gernot Kriegshauser, Christian Oberkanins, Rami Mahfouzhttp://www.nature.com/articles/s41598-017-04948-3.pdf, http://www.nature.com/articles/s41598-017-04948-3, http://www.nature.com/articles/s41598-017-04948-3.pdf
Yearbook of Surgery10.1016/s0090-3671(10)79723-820102010165-166Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutationT.J. Faheyhttp://api.elsevier.com/content/article/PII:S0090367110797238?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S0090367110797238?httpAccept=text/plain
APMIS10.1111/j.1600-0463.2011.02844.x20111205380-386BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patientsHANNA PELTTARI, CAMILLA SCHALIN-JÄNTTI, JOHANNA AROLA, ELIISA LÖYTTYNIEMI, SAKARI KNUUTILA, MATTI J. VÄLIMÄKIhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0463.2011.02844.x
The Laryngoscope10.1002/lary.2466820141249E389-E393BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinomaDaniel J. Givens, Luke O. Buchmann, Archana M. Agarwal, Johannes F. Grimmer, Jason P. Hunthttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Flary.24668
Endocrinology and Metabolism10.3803/enm.2014.29.4.5362014294536Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic SignificanceMin Jung Jung, Su Kyoung Kwonhttp://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2014.29.4.536
BMC Cancer10.1186/1471-2407-14-3832014141Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinomaYanhong Huang, Wenwu Dong, Jing Li, Hao Zhang, Zhongyan Shan, Weiping Tenghttp://link.springer.com/content/pdf/10.1186/1471-2407-14-383.pdf, http://link.springer.com/article/10.1186/1471-2407-14-383/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-14-383